Lipotoxicity in kidney, heart, and skeletal muscle dysfunction

128Citations
Citations of this article
146Readers
Mendeley users who have this article in their library.

Abstract

Dyslipidemia is a common nutritional and metabolic disorder in patients with chronic kidney disease. Accumulating evidence supports the hypothesis that prolonged metabolic imbalance of lipids leads to ectopic fat distribution in the peripheral organs (lipotoxicity), including the kidney, heart, and skeletal muscle, which accelerates peripheral inflammation and affictions. Thus, lipotoxicity may partly explain progression of renal dysfunction and even extrarenal complications, including renal anemia, heart failure, and sarcopenia. Additionally, endoplasmic reticulum stress activated by the unfolded proteinresponse pathway plays a pivotal role in lipotoxicity by modulating the expression of key enzymes in lipid synthesis and oxidation. Here,we review the molecular mechanisms underlying lipid deposition and resultant tissue damage in the kidney, heart, and skeletal muscle, with the goal of illuminating the nutritional aspects of these pathologies.

Cite

CITATION STYLE

APA

Nishi, H., Higashihara, T., & Inagi, R. (2019, July 1). Lipotoxicity in kidney, heart, and skeletal muscle dysfunction. Nutrients. MDPI AG. https://doi.org/10.3390/nu11071664

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free